IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Oncogene

• Publication date

  2000-05-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1203587PMID 10851068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PTEN Interactions with Focal Adhesion Kinase and Suppression of the Extracellular Matrix-dependent Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway*

  1999influential reference
• Tyrosine phosphorylation of C-Cbl facilitates adhesion and spreading while suppressing anchorage-independent growth of V-Abl-transformed NIH3T3 fibroblasts

  1999cited by this paper
• PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis

  1999cited by this paper
• Dissociation between resistance to apoptosis and the transformed phenotype in IGF‐I receptor signaling

  1999cited by this paper
• Anti-apoptotic signaling of the IGF-I receptor in fibroblasts following loss of matrix adhesion

  1999influential reference
• Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis

  1999cited by this paper
• IGFs and Cell Growth

  1999cited by this paper
• Growth and Differentiation Signals by the Insulin-like Growth Factor 1 Receptor in Hemopoietic Cells Are Mediated through Different Pathways*

  1999influential reference
• Synthetic peptide sequence from the C‐terminus of the insulin‐like growth factor‐I receptor that induces apoptosis and inhibition of tumor growth

  1999influential reference
• Cross-talk between Insulin Receptor and Integrin α5β1 Signaling Pathways*

  1998cited by this paper
• The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.

  1998influential reference
• Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells

  1998cited by this paper
• Stimulation of IRS-1-associated Phosphatidylinositol 3-Kinase and Akt/Protein Kinase B but Not Glucose Transport by β1-Integrin Signaling in Rat Adipocytes*

  1998cited by this paper
• PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.

  1998cited by this paper
• Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells.

  1998cited by this paper
• Insulin‐like growth factor‐I‐mediated survival from Anoikis: Role of cell aggregation and focal adhesion kinase

  1998influential reference
• Role of binding proteins to IRS-1 in insulin signalling

  1998cited by this paper
• The COOH-terminal Tyrosine Phosphorylation Sites on IRS-1 Bind SHP-2 and Negatively Regulate Insulin Signaling*

  1998cited by this paper
• Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.

  1998influential reference
• Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

  1998cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.

  1997cited by this paper
• Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

  1997cited by this paper
• Reexpression of the type 1 insulin-like growth factor receptor inhibits the malignant phenotype of simian virus 40 T antigen immortalized human prostate epithelial cells.

  1997cited by this paper
• Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

  1997cited by this paper
• Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

  1997cited by this paper
• Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain.

  1997cited by this paper
• Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.

  1996influential reference
• Neoplastic Transformation Induced by Insulin Receptor Substrate-1 Overexpression Requires an Interaction with Both Grb2 and Syp Signaling Molecules*

  1996cited by this paper
• Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.

  1996cited by this paper
• Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3).

  1995cited by this paper
• Association of insulin receptor substrate-1 with integrins.

  1994cited by this paper
• Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.

  1993cited by this paper
• Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.

  1991influential reference

• PI3K/Akt inhibition promotes AR activity and prostate cancer cell proliferation through p35-CDK5 modulation.

  2024cites this paper
• The Insulin Receptor Substrate 2 Mediates the Action of Insulin on HeLa Cell Migration via the PI3K/Akt Signaling Pathway

  2023cites this paper
• Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment

  2021cites this paper
• In uence of Insulin-Like Growth Factor 1 Gene Expression in Women with Breast Cancer: A Systematic Review

  2020cites this paper
• IRS-1 regulates proliferation, invasion and metastasis of pancreatic cancer cells through MAPK and PI3K signaling pathways.

  2018cites this paper
• Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy

  2017cites this paper
• Role of Macrophages in the Development of Castration-Resistant Prostate Cancer

  2016cites this paper
• Transmembrane prostatic acid phosphatase (TMPAP) delays cells in G1 phase of the cell cycle

  2016cites this paper
• MiR200c targets IRS1 and suppresses prostate cancer cell growth

  2015cites this paper
• Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer

  2015cites this paper
• Genetic Modulation of Neurocognitive Function in Glioma Patients

  2015cites this paper
• The Tyrphostin NT157 Suppresses Insulin Receptor Substrates and Augments Therapeutic Response of Prostate Cancer

  2014cites this paper
• Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells

  2014influential citation
• MetastasisPromotes Mammary Tumor Suppression of Insulin Receptor Substrate

  2014cites this paper
• Insulin receptor compensates for IGF1R inhibition and directly induces mitogenic activity in prostate cancer cells

  2014cites this paper
• miR-23a-mediated migration/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells

  2014cites this paper
• Effect of simvastatin on castration-resistant prostate cancer cells

  2014cites this paper
• Small Molecule Therapeutics The Tyrphostin NT 157 Suppresses Insulin Receptor Substrates and Augments Therapeutic Response of Prostate Cancer

  2014cites this paper
• Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy

  2014cites this paper
• IGF-1R inhibition enhances radiosensitivity and delays double-strand break repair by both non-homologous end-joining and homologous recombination

  2013cites this paper
• Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis.

  2013cites this paper
• Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer

  2013cites this paper
• Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871)

  2013cites this paper
• The Role of the Dysfunctional Akt-Related Pathway in Cancer: Establishment and Maintenance of a Malignant Cell Phenotype, Resistance to Therapy, and Future Strategies for Drug Development

  2013cites this paper
• Neuronal Insulin Receptor Signaling: A Potential Target for the Treatment of Cognitive and Mood Disorders

  2013cites this paper
• Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients

  2012cites this paper
• Nuclear IRS‐1 and cancer

  2012cites this paper
• Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks.

  2012cites this paper
• Serial analysis of resected prostate cancer suggests up‐regulation of type 1 IGF receptor with disease progression

  2011cites this paper
• The prognostic significance of the insulin‐like growth factor‐1 ligand and receptor expression in breast cancer tissue

  2011cites this paper
• Mutual interaction and reciprocal down‐regulation between c‐met and insulin receptor substrate‐1

  2010cites this paper
• IGF-IR in neuroprotection and brain tumors.

  2009cites this paper
• The B cell translocation gene (BTG) family in the rat ovary: hormonal induction, regulation, and impact on cell cycle kinetics.

  2009cites this paper
• Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition.

  2009cites this paper
• Università degli Studi di Ferrara DOTTORATO DI RICERCA IN " Farmacologia e Oncologia Molecolare "

  2009cites this paper
• Is PTEN loss associated with clinical outcome measures in human prostate cancer?

  2008cites this paper
• Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis

  2008cites this paper
• Antineoplastic effect of rapamycin is potentiated by inhibition of IRS-1 signaling in prostate cancer cells xenografts

  2008cites this paper
• Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance

  2008cites this paper
• In Vivo Activity of Insulin-Like Growth Factor Binding Protein-3 in Prevention of Prostate Cancer Progression

  2008cites this paper
• Modulation of cell growth and apoptosis response in human prostate cancer cells supplemented with tocotrienols

  2008cites this paper
• Divergent Roles for IRS-1 and IRS-2 in Breast Cancer Metastasis

  2007cites this paper
• Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.

  2007cites this paper
• Imidazole moiety replacements in the 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one inhibitors of insulin-like growth factor receptor-1 (IGF-1R) to improve cytochrome P450 profile.

  2007cites this paper
• Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.

  2006cites this paper
• Insulin-like Growth Factor I Secreted from Prostate Stromal Cells Mediates Tumor-Stromal Cell Interactions of Prostate Cancer

  2006cites this paper
• IGF1R signalling and its inhibition.

  2006cites this paper
• the Insulin-Like Growth Factor / AKT Signaling Pathway Coordinately Regulate the Transcription of Components of Steroid Receptor Coactivator-3 and Activator Protein-1

  2006cites this paper
• Disruption of metabolic pathways--perspectives for the treatment of cancer.

  2006cites this paper
• Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer.

  2006influential citation
• Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.

  2006cites this paper
• Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis

  2006cites this paper
• Suppression of Insulin Receptor Substrate 1 (IRS-1) Promotes Mammary Tumor Metastasis

  2006cites this paper
• Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.

  2006cites this paper
• Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: Strong association of IRS1 G972R variant and cancer risk

  2005cites this paper
• Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.

  2005cites this paper
• Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer

  2005influential citation
• Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases

  2005cites this paper
• Expression of the Insulin Receptor Substrate 1 in primary tumors and lymph node metastases in breast cancer: correlations with Bcl-xL and Bax proteins.

  2005cites this paper
• Tuberous Sclerosis and Insulin Resistance: Unlikely Bedfellows Reveal A TORrid Affair

  2005cites this paper
• Impaired homologous recombination DNA repair and enhanced sensitivity to DNA damage in prostate cancer cells exposed to anchorage-independence

  2005influential citation
• Insulin-like growth factor-I signaling in human neuroblastoma cells

  2004cites this paper
• Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins

  2004cites this paper
• Selective Activation of Insulin Receptor Substrate-1 and -2 in Pleural Mesothelioma Cells

  2004cites this paper
• Increased Insulin-Like Growth Factor I Receptor Expression and Signaling Are Components of Androgen-Independent Progression in a Lineage-Derived Prostate Cancer Progression Model

  2004cites this paper
• PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells

  2004cites this paper
• Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy

  2004cites this paper
• Progression Model Progression in a Lineage-Derived Prostate Cancer and Signaling Are Components of Androgen-Independent Increased Insulin-Like Growth Factor I Receptor Expression

  2004cites this paper
• A Highly Conserved NTRK3 C-terminal Sequence in the ETV6-NTRK3 Oncoprotein Binds the Phosphotyrosine Binding Domain of Insulin Receptor Substrate-1

  2004cites this paper
• Regulation of Apoptosis in Prostate Cancer

  2004cites this paper
• The Insulin-like Growth Factors and Insulin-signalling Systems: An Appealing Target for Breast Cancer Therapy?

  2003cites this paper
• Regulation of IGF-I Receptor Signaling in Tumor Cells

  2003cites this paper
• The complex biology of the receptor for the insulin-like growth factor-1.

  2003cites this paper
• Gene amplifications associated with the development of hormone-resistant prostate cancer.

  2003cites this paper
• Role of the Insulin-Like Growth Factor I/Insulin Receptor Substrate 1 Axis in Rad51 Trafficking and DNA Repair by Homologous Recombination

  2003cites this paper
• Homologous Recombination Rad 51 Trafficking and DNA Repair by I / Insulin Receptor Substrate 1 Axis in Role of the Insulin-Like Growth Factor

  2003cites this paper
• Regulation of normal and malignant prostate cell biology by IGF-I: mechanisms and modulation by dietary polyphenols and energy restriction

  2003cites this paper
• Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase.

  2003cites this paper
• The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?

  2003cites this paper
• Development of Molecular Agents for IGF Receptor Targeting

  2003cites this paper
• Insulin Receptor Substrate 1 Translocation to the Nucleus by the Human JC Virus T-antigen*

  2002cites this paper
• Insulin-like growth factor I receptor activity in human medulloblastomas.

  2002cites this paper
• Persists in Metastatic Disease Is Up-Regulated in Primary Prostate Cancer and Commonly Expression of the Type 1 Insulin-like Growth Factor Receptor Updated

  2002influential citation
• Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.

  2002influential citation
• Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.

  2002cites this paper
• Insulin-like Growth Factor I Receptor Activity in Human Medulloblastomas 1

  2002cites this paper
• Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells

  2001cites this paper
• In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).

  2001cites this paper
• Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas

  2001cites this paper
• Regulation of Id2 Gene Expression by the Insulin-like Growth Factor I Receptor Requires Signaling by Phosphatidylinositol 3-Kinase*

  2001cites this paper
• Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.

  2001cites this paper
• The contradictions of the insulin-like growth factor 1 receptor

  2000influential citation
• Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential

  2000cites this paper
• Digital Commons@Becker Digital Commons@Becker

  year unknowncites this paper